Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 739 participants.

Also called NCT03011346

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 739 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03011346
Main results
  • Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial Lancet (London, England), 2019-11-02 DOI, PubMed 31570258
Other papers using this trial's data
  • Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic Valve Circulation. Cardiovascular interventions, 2023-07 DOI, PubMed 37417229
  • Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve Replacement: A Post Hoc Analysis of the SCOPE I Randomized Clinical Trial JAMA network open, 2025-12-01 DOI, PubMed 41364435, PMC12690430 In the PMC Open Access subset under CC BY.
  • Relationship between baseline patient-reported health status and patient-centered outcomes after transcatheter aortic valve replacement American heart journal, 2026-10 DOI, PubMed 42203165

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03011346. Randomized; no masking; primary purpose treatment. Start 2017-02-08 (actual); primary completion 2019-05-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.
Acronym
SCOPE I
Condition
Aortic Valve Stenosis
Intervention (Device)
Symetis ACURATE neo/TF transfemoral TAVI system
Intervention (Device)
Edwards Sapien 3 Transcatheter Heart Valve
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct03011346
Content hash
d4b48d3c081d557f2b68f4ca0ad7d95deb9f809e2c7f4917e5b0a1132157423b